These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
662 related articles for article (PubMed ID: 35104836)
1. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Hui KPY; Ho JCW; Cheung MC; Ng KC; Ching RHH; Lai KL; Kam TT; Gu H; Sit KY; Hsin MKY; Au TWK; Poon LLM; Peiris M; Nicholls JM; Chan MCW Nature; 2022 Mar; 603(7902):715-720. PubMed ID: 35104836 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells. Zhao H; Lu L; Peng Z; Chen LL; Meng X; Zhang C; Ip JD; Chan WM; Chu AW; Chan KH; Jin DY; Chen H; Yuen KY; To KK Emerg Microbes Infect; 2022 Dec; 11(1):277-283. PubMed ID: 34951565 [TBL] [Abstract][Full Text] [Related]
3. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Meng B; Abdullahi A; Ferreira IATM; Goonawardane N; Saito A; Kimura I; Yamasoba D; Gerber PP; Fatihi S; Rathore S; Zepeda SK; Papa G; Kemp SA; Ikeda T; Toyoda M; Tan TS; Kuramochi J; Mitsunaga S; Ueno T; Shirakawa K; Takaori-Kondo A; Brevini T; Mallery DL; Charles OJ; ; ; ; Bowen JE; Joshi A; Walls AC; Jackson L; Martin D; Smith KGC; Bradley J; Briggs JAG; Choi J; Madissoon E; Meyer KB; Mlcochova P; Ceron-Gutierrez L; Doffinger R; Teichmann SA; Fisher AJ; Pizzuto MS; de Marco A; Corti D; Hosmillo M; Lee JH; James LC; Thukral L; Veesler D; Sigal A; Sampaziotis F; Goodfellow IG; Matheson NJ; Sato K; Gupta RK Nature; 2022 Mar; 603(7902):706-714. PubMed ID: 35104837 [TBL] [Abstract][Full Text] [Related]
4. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron. Shuai H; Chan JF; Hu B; Chai Y; Yuen TT; Yin F; Huang X; Yoon C; Hu JC; Liu H; Shi J; Liu Y; Zhu T; Zhang J; Hou Y; Wang Y; Lu L; Cai JP; Zhang AJ; Zhou J; Yuan S; Brindley MA; Zhang BZ; Huang JD; To KK; Yuen KY; Chu H Nature; 2022 Mar; 603(7902):693-699. PubMed ID: 35062016 [TBL] [Abstract][Full Text] [Related]
5. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection. Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850 [TBL] [Abstract][Full Text] [Related]
6. Replication of SARS-CoV-2 Omicron BA.2 variant in ex vivo cultures of the human upper and lower respiratory tract. Hui KPY; Ng KC; Ho JCW; Yeung HW; Ching RHH; Gu H; Chung JCK; Chow VLY; Sit KY; Hsin MKY; Au TWK; Poon LLM; Peiris M; Nicholls JM; Chan MCW EBioMedicine; 2022 Sep; 83():104232. PubMed ID: 35988466 [TBL] [Abstract][Full Text] [Related]
7. Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents. Ma C; Chen X; Mei F; Xiong Q; Liu Q; Dong L; Liu C; Zou W; Zhan F; Hu B; Liu Y; Liu F; Zhou L; Xu J; Jiang Y; Xu K; Cai K; Chen Y; Yan H; Lan K Emerg Microbes Infect; 2022 Dec; 11(1):567-572. PubMed ID: 35060426 [TBL] [Abstract][Full Text] [Related]
8. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Suzuki R; Yamasoba D; Kimura I; Wang L; Kishimoto M; Ito J; Morioka Y; Nao N; Nasser H; Uriu K; Kosugi Y; Tsuda M; Orba Y; Sasaki M; Shimizu R; Kawabata R; Yoshimatsu K; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; ; Sawa H; Ikeda T; Irie T; Matsuno K; Tanaka S; Fukuhara T; Sato K Nature; 2022 Mar; 603(7902):700-705. PubMed ID: 35104835 [TBL] [Abstract][Full Text] [Related]
9. Exploration of the ocular surface infection by SARS-CoV-2 and implications for corneal donation: An ex vivo study. Maurin C; He Z; Mentek M; Verhoeven P; Pillet S; Bourlet T; Rogues F; Pugniet JL; Peyragrosse T; Barallon M; Perrache C; Aouimeur I; Acquart S; Ninotta S; Baud'huin M; Vabres B; Poinard S; Gain P; Thuret G PLoS Med; 2022 Mar; 19(3):e1003922. PubMed ID: 35231027 [TBL] [Abstract][Full Text] [Related]
10. The Omicron variant BA.1.1 presents a lower pathogenicity than B.1 D614G and Delta variants in a feline model of SARS-CoV-2 infection. Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG bioRxiv; 2022 Jun; ():. PubMed ID: 35734088 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Omicron Induces Enhanced Mucosal Interferon Response Compared to other Variants of Concern, Associated with Restricted Replication in Human Lung Tissues. Alfi O; Hamdan M; Wald O; Yakirevitch A; Wandel O; Oiknine-Djian E; Gvili B; Knoller H; Rozendorn N; Golan Berman H; Adar S; Vorontsov O; Mandelboim M; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG Viruses; 2022 Jul; 14(7):. PubMed ID: 35891570 [TBL] [Abstract][Full Text] [Related]
12. Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways. Iwata-Yoshikawa N; Kakizaki M; Shiwa-Sudo N; Okura T; Tahara M; Fukushi S; Maeda K; Kawase M; Asanuma H; Tomita Y; Takayama I; Matsuyama S; Shirato K; Suzuki T; Nagata N; Takeda M Nat Commun; 2022 Oct; 13(1):6100. PubMed ID: 36243815 [TBL] [Abstract][Full Text] [Related]
13. TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection. Metzdorf K; Jacobsen H; Greweling-Pils MC; Hoffmann M; Lüddecke T; Miller F; Melcher L; Kempf AM; Nehlmeier I; Bruder D; Widera M; Ciesek S; Pöhlmann S; Čičin-Šain L Viruses; 2023 Jan; 15(2):. PubMed ID: 36851486 [TBL] [Abstract][Full Text] [Related]
14. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein. Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115 [TBL] [Abstract][Full Text] [Related]
15. Insights into the Replication Kinetics Profiles of Malaysian SARS-CoV-2 Variant Alpha, Beta, Delta, and Omicron in Vero E6 Cell Line. Mohd Zawawi Z; Kalyanasundram J; Mohd Zain R; Mat Ripen A; Basri DF; Yap WB Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408868 [TBL] [Abstract][Full Text] [Related]
16. Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review. Kannan S; Shaik Syed Ali P; Sheeza A Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8019-8022. PubMed ID: 34982466 [TBL] [Abstract][Full Text] [Related]
17. Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell. Puray-Chavez M; LaPak KM; Schrank TP; Elliott JL; Bhatt DP; Agajanian MJ; Jasuja R; Lawson DQ; Davis K; Rothlauf PW; Liu Z; Jo H; Lee N; Tenneti K; Eschbach JE; Shema Mugisha C; Cousins EM; Cloer EW; Vuong HR; VanBlargan LA; Bailey AL; Gilchuk P; Crowe JE; Diamond MS; Hayes DN; Whelan SPJ; Horani A; Brody SL; Goldfarb D; Major MB; Kutluay SB Cell Rep; 2021 Jul; 36(2):109364. PubMed ID: 34214467 [TBL] [Abstract][Full Text] [Related]